- Eat Well, Test Well: Bayer HealthCare and dLife Healthcare Solutions launch diabetes resource
- Three new Takeda diabetes drugs become available
- Study: Type 2 diabetes market competition heats up amid disease rate increase
- Patients on Type 2 diabetes drugs may experience dangerously low blood sugar despite lack of disease control, study finds
- BD launches needle aimed at diabetics
MINNEAPOLIS — Medtronic has launched a blood-glucose monitor that allows remote monitoring of blood-glucose levels, the company said.
The Minneapolis-based device maker announced the Food and Drug Administration approval and launch of the mySentry remote glucose monitor, which allows a parent or caregiver to monitor a patient's blood-sugar levels from another room by communicating with the MiniMed Paradigm Real-Time Revel glucose-monitoring system.
The new device allows caregivers to see real-time insulin pump status and glucose trends and hear alerts while an adult or child with diabetes sleeps in another room. For example, if a child's glucose levels are falling in the middle of the night, an alarm will allow them to take action. According to one study, about 75% of all episodes of abnormally low blood sugar in children, also known as hypoglycemia, occur at night.